SC 13G

Company

PLUS THERAPEUTICS, INC.

Filed

May 14, 2020

Accession Number

0001019056-20-000342

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →